Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Oncotarget|September 4, 2015
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancerEveline M Dijkgraaf, Saskia J A M Santegoets, An K L Reyners, et al.Clinical and Translational Radiation Oncology|February 12, 2026
Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapyAnouk Corbeau, Marij J P Welters, Sanne Boekestijn, et al.Cancers|October 23, 2021
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune SystemAnouk Corbeau, Remi A Nout, Jan Willem M Mens, et al.Gynecologic Oncology|October 12, 2020
Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trialMarion M Deken, Helena C van Doorn, Danielle Verver, et al.Journal of Translational Medicine|April 6, 2013
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trialMariette I E van Poelgeest, Marij J P Welters, Edith M G van Esch, et al.Journal for Immunotherapy of Cancer|October 19, 2022
Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesionsFrank M Speetjens, Marij J P Welters, Marije Slingerland, et al.Science Translational Medicine|March 20, 2020
Strong vaccine responses during chemotherapy are associated with prolonged cancer survivalCornelis J M Melief, Marij J P Welters, Ignace Vergote, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 29, 2019
Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar CancerKim E Kortekaas, Koen K Van de Vijver, Mariëtte I E van Poelgeest, et al.Cancer Immunology, Immunotherapy : CII|November 16, 2013
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II studyPeggy J de Vos van Steenwijk, Mariette I E van Poelgeest, Tamara H Ramwadhdoebe, et al.European Journal of Cancer (Oxford, England : 1990)|August 9, 2020
Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands - A nationwide population-based studyMichiel C T van Zeijl, Florine L Boer, Mariëtte I E van Poelgeest, et al.Pageof 9